New Path Molecular is going Beyond ADCs. We us cutting edge chemistry techniques to develop novel, fully synthetic drug conjugates for pan-tumour biomarkers which address the limitations of conventional Antibody Drug Conjugates. Our first indications are pancreatic and colorectal cancer.
Company Details
- Employees
- 6
- Founded
- 2015
- Address
- Cambridge
- in****@****lar.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- newpathmolecular.com
- Keywords
- synthesis of complex functional molecules, natural products, peptides, macrocycles, flow chemistry, Drug Conjugates, Oncology.
- HQ
- Cambridge
New Path Molecular Research Questions
New Path Molecular Research's website is newpathmolecular.com
New Path Molecular Research's LinkedIn profile is https://uk.linkedin.com/company/new-path-molecular-research
New Path Molecular Research has
6 employees.
View email and phone details for 6
employees at New Path Molecular Research.
New Path Molecular Research's industry is
Biotechnology Research
New Path Molecular Research's top competitors are
The Microcurrent Site Ltd,
Immunoquest Therapeutics,
Alchemab Therapeutics Ltd,
Dam Salud,
Mestag Therapeutics,
Kargenera (Currently In Stealth Mode),
Isogenica,
Cambridge Consultants,
B3 Labs,
Bicycle Therapeutics.
New Path Molecular Research's support email address is info@newpathmolecular.com
New Path Molecular Research's categories are Biotechnology Research
New Path Molecular Research's founding year is 2015
